ID
36223
Descrizione
NCT00428090 / GSK-AVA105640 A 24-week, double-blind, double-dummy, randomized, parallel-group study to investigate the effects of rosiglitazone (extended release tablets), donepezil, and placebo as monotherapy on cognition and overall clinical response in APOE e4-stratified subjects with mild to moderate Alzheimer’s disease. (REFLECT-1) A serious adverse event is any untoward medical occurence taht, at any dose: a) results in death. b) is life-threatening. Note: The term "life-threatening" in the definition of "serious" refers to an event in which the subject was at risk of death at the time of the event. It dies not refer to an event, which hypothetically might have caused death, if it were more severe. c) requires hospitalisation or prolongation of existing hospitalisation. Note: In general, hospitalisation signifies that the subject has been detained (usually involving at least an overnight stay9 at the hospital or emergency ward fro observation and/or treatment that would not have been appropriate in the physicican's office or out-patient setting. Complications that occur during hospitalisation are AEs. If a complication prolongs hopsialisation or fulfills any other serious criteria, the event is "serious". When in doubt as to whether "hospitalisation" occured or was necessary, the AE should be considered "serious". Hospitalisation for elective treatment of pre-existing condition that did not worsen from baseline is not considered an AE. d) results in disability/incapacity, or Note: the term disability means a sbustantial disruption of a person's ability to conduct normal life functions. This definition is not intended to include experiences of relatively minor medical significance such as uncomplicated headache, nausea, vomiting, diarrhoea, influenza, and accidental trauma (e.g., sprained ankle) which may interfere or prevent everyday life functions but do not consitute a substantial disruption. e) is a congenital anomaly/birht defect. f) other. Medical or scientific judgement should be exercised in deiding whether reporting is appropriate in other situations, such as important medical events that may not be immedaitely life-threatening or result in death or hospitalisation but may jeopardise the subejct or may require medical or surgical intervention to prevent one of the other outcomes listed in the above definition. These should also be considered serious. Examples of such events are invasive or malignant cancers, intensive treatment in an emergency room or at home for allergic bronchospasm, blood dyscrasias or convusions that do not result in hospitalisation, or development of drug dependency or drug abuse.
Keywords
versioni (3)
- 27/09/17 27/09/17 -
- 27/09/17 27/09/17 -
- 23/04/19 23/04/19 - Sarah Riepenhausen
Titolare del copyright
GlaxoSmithKline
Caricato su
23 aprile 2019
DOI
Per favore, per richiedere un accesso.
Licenza
Creative Commons BY-NC-ND 3.0
Commenti del modello :
Puoi commentare il modello dati qui. Tramite i fumetti nei gruppi di articoli e articoli è possibile aggiungere commenti a quelli in modo specifico.
Commenti del gruppo di articoli per :
Commenti dell'articolo per :
Per scaricare i modelli di dati devi essere registrato. Per favore accesso o registrati GRATIS.
REFLECT-1 Serious Adverse Events NCT00428090
REFLECT-1 Serious Adverse Events NCT00428090
- StudyEvent: ODM
Descrizione
Serious Adverse Event: Seriousness - Section 2
Alias
- UMLS CUI-1
- C1710056
Descrizione
Serious Adverse Event: Ongoing Event - Section 4
Alias
- UMLS CUI-1
- C0580798
Descrizione
Ongoing event
Tipo di dati
text
Alias
- UMLS CUI [1]
- C0580798
Descrizione
Serious Adverse Event: Relevant Medical Condition - Section 6
Alias
- UMLS CUI-1
- C0012634
Descrizione
Serious Adverse Event: RELEVANT Concomitant Medication (include details of any concomitant medication(s) which may have contributed to the event) - Section 8
Alias
- UMLS CUI-1
- C2347852
Descrizione
Drug Name
Tipo di dati
text
Alias
- UMLS CUI [1]
- C2360065
Descrizione
Unit
Tipo di dati
text
Alias
- UMLS CUI [1]
- C1519795
Descrizione
Route
Tipo di dati
text
Alias
- UMLS CUI [1]
- C0013153
Descrizione
Start Date
Tipo di dati
date
Unità di misura
- dd/MMM/yy
Alias
- UMLS CUI [1]
- C0808070
Descrizione
Ongoing Medication
Tipo di dati
boolean
Alias
- UMLS CUI [1]
- C2826666
Descrizione
Serious Adverse Event: Assessment - Section 10
Alias
- UMLS CUI-1
- C1516048
Descrizione
Identification and Signature
Alias
- UMLS CUI-1
- C0205396
- UMLS CUI-2
- C1519316
Descrizione
Date of report
Tipo di dati
date
Unità di misura
- dd/MMM/yy
Alias
- UMLS CUI [1]
- C1302584
Descrizione
Investigator's Signature
Tipo di dati
text
Alias
- UMLS CUI [1]
- C2346576
Similar models
REFLECT-1 Serious Adverse Events NCT00428090
- StudyEvent: ODM
C2348235 (UMLS CUI [1,2])
C0877248 (UMLS CUI [1,2])
C2348235 (UMLS CUI [1,2])
C0011008 (UMLS CUI [1,2])
C1519316 (UMLS CUI-2)